市場調査レポート
商品コード
1159388
世界の放射線量管理市場(2022年~2028年)Radiation Dose Management Market 2022-2028 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
世界の放射線量管理市場(2022年~2028年) |
出版日: 2022年10月20日
発行: Orion Market Research
ページ情報: 英文 120 Pages
納期: 2~3営業日
|
世界の放射線量管理の市場規模は、予測期間中に14.6%の大幅なCAGRで成長すると予想されています。市場の成長を後押しする主な要因には、慢性疾患の有病率の上昇、放射線量管理に対する意識の高まりなどが挙げられます。一方で、放射線量管理ソリューションの導入が少ないことや、放射線量管理ソリューションを収集するための償還が行われていないことなどが、市場の成長を妨げる要因の一つとなっています。
当レポートでは、世界の放射線量管理市場を調査しており、市場の概要、市場動向の分析、モダリティ別・タイプ別・エンドユーザー別・地域別の分析、競合情勢、さらに主要企業のプロファイルなど、包括的な情報を提供しています。
Global Radiation Dose Management Market Size, Share & Trends Analysis Report, by Modality (Computed Tomography, Fluoroscopy, and Interventional Imaging, Radiography and Mammography, and Nuclear Medicine), by Type (Solution, Software, and Services) and by End-User (Hospitals, Ambulatory Care Settings, and Others) Forecast Period (2022-2028)
The global radiation dose management market is anticipated to grow at a significant CAGR of 14.6% during the forecast period. The rising prevalence of chronic diseases coupled with the increasing awareness of radiation dose management are factors that are boosting the growth of the global radiation dose management market. However, the low implementation of radiation dose management solutions and lack of reimbursement for collecting radiation dose management solutions are some factors that are hindering the growth of the global market.
The global radiation dose management market is segmented based on the modality, type, and end-user. Based on the modality, the market is segmented into computed tomography, fluoroscopy and interventional imaging, radiography and mammography, and nuclear medicine. Based on the type, the market is sub-segmented into the solution, software, and services. Based on the end-user, the market is sub-segmented into the hospitals, ambulatory care settings, and others. The above-mentioned segments can be customized as per the requirements. The fluoroscopy and interventional imaging segment are expected to grow during the forecast period as many key players are launching their new products to stay competitive in the market. For instance, In June 2021, FUJIFILM Medical Systems U.S.A., Inc., introduced the Persona RF PREMIUM in the US. The Persona RF PREMIUM is a creative radiography and fluoroscopy system developed for hospitals and medical centers of all sizes, delivering real-time imaging for skeletal, digestive, urinary, respiratory, reproductive systems; and specific organs including the heart, lung, and kidneys.
Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The North American segment is expected to hold a significant share in the global radiation dose management market due to an increase in the rising prevalence of chronic diseases such as cancer, stroke, cardiac disease, and others in this region. According to the American Cancer Society, Inc. in 2021, there will be an estimated 1.9 million new cancer cases diagnosed and 608,570 cancer deaths in the US.
The major companies serving the global radiation dose management market include Agfa HealthCare N.V., Bayer AG, Bracco Imaging S.p.A., Fujifilm Corp., General Electric Co., INFINITT Healthcare Co., Ltd., Mckesson Corp., Sectra AB, and PACSHealth, LLC., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in March 2019, Fujifilm Medical Systems USA announced that it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory requirements for three new image processing and software advancements for its digital mammography system, S-View, Iterative Super-resolution Reconstruction (ISR), and Tomosynthesis Spot. These innovative tools are developed to satisfy the dual challenge of higher image quality and lower dose.
Research Methodology
The market study of the global radiation dose management market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of the market size, and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers: